256 related articles for article (PubMed ID: 17513158)
1. [Haemovigilance donors: methods and results].
Rebibo D; Danic B
Transfus Clin Biol; 2007 May; 14(1):142-6. PubMed ID: 17513158
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infections.
Pillonel J; Barin F; Laperche S; Bernillon P; Le Vu S; Brunet S; Thierry D; Desenclos JC;
Transfusion; 2008 Aug; 48(8):1567-75. PubMed ID: 18482193
[TBL] [Abstract][Full Text] [Related]
3. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
[TBL] [Abstract][Full Text] [Related]
4. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
5. Blood donors--Serious adverse reactions (SAR) 2010-2014 EFS Châteauroux, France.
Riga A; Sapey T; Bacanu M; Py JY; Dehaut F
Transfus Clin Biol; 2015 Jun; 22(2):62-5. PubMed ID: 25997383
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
[TBL] [Abstract][Full Text] [Related]
7. Limited effectiveness of donor deferral registries for transfusion-transmitted disease markers.
Cable R; Musavi F; Notari E; Zou S;
Transfusion; 2008 Jan; 48(1):34-42. PubMed ID: 17894796
[TBL] [Abstract][Full Text] [Related]
8. The French Haemovigilance System: organization and results for 2003.
Rebibo D; Hauser L; Slimani A; Hervé P; Andreu G
Transfus Apher Sci; 2004 Oct; 31(2):145-53. PubMed ID: 15501418
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of pre- and post-transfusion serological screening in France in 2001].
Daurat G; Fressy P; Duedari N; Le Blanc G; Taverne D; Ounnoughène N; Pillonel J
Transfus Clin Biol; 2004 Jul; 11(3):153-60. PubMed ID: 15488728
[TBL] [Abstract][Full Text] [Related]
10. A method for estimating incidence rate of infectious diseases among first-time blood donors.
Zou S; Fang CT; Dodd RY
Transfusion; 2008 Sep; 48(9):1827-32. PubMed ID: 18482184
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
[TBL] [Abstract][Full Text] [Related]
12. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay.
Chevrier MC; St-Louis M; Perreault J; Caron B; Castilloux C; Laroche J; Delage G
Transfusion; 2007 Oct; 47(10):1794-802. PubMed ID: 17880603
[TBL] [Abstract][Full Text] [Related]
13. Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil.
Maresch C; Schluter PJ; Wilson AD; Sleigh A
Transfusion; 2008 Feb; 48(2):273-81. PubMed ID: 18005323
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
[TBL] [Abstract][Full Text] [Related]
15. [The blood donors' haemovigilance in France].
Ounnoughene N; Sandid I; Carlier M; Joussemet M; Ferry N
Transfus Clin Biol; 2013 May; 20(2):182-92. PubMed ID: 23587615
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiological surveillance of blood donors and residual risk of blood-borne infections in France, 2001 to 2003].
Pillonel J; Le Marrec N; Girault A; David D; Laperche S
Transfus Clin Biol; 2005 Jul; 12(3):239-46. PubMed ID: 15963749
[TBL] [Abstract][Full Text] [Related]
17. Donors' blood group declaration before donation can be used as a tool for electronic crossmatching.
Arslan O
Transfus Med; 2005 Dec; 15(6):487-92. PubMed ID: 16359420
[TBL] [Abstract][Full Text] [Related]
18. [Stating technical requirements and deferral criteria for whole blood donation].
Danic B
Transfus Clin Biol; 2005 Jul; 12(3):287-9. PubMed ID: 15963750
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and biological qualifications for blood donations].
Danic B; Piquet Y
Rev Prat; 2001 Jun; 51(12):1299-305. PubMed ID: 11503502
[TBL] [Abstract][Full Text] [Related]
20. Retrospective surveillance of HIV prevalence in blood donors can help in the selection of the best social group for blood donation in Mali.
Tounkara A; Diakite M; Noumsi GT; Sarro YD; Siddiqui S; Parta M
Transfus Med; 2009 Oct; 19(5):252-9. PubMed ID: 19747288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
